Arbutus Biopharma Corporation ABUS Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
Based on trailing twelve months.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's earnings yield?
- Arbutus Biopharma Corporation (ABUS) reported earnings yield of 18.3% in Q1 2026.
- How has Arbutus Biopharma Corporation's earnings yield changed year-over-year?
- Arbutus Biopharma Corporation's earnings yield increased by 259.5% year-over-year, from -11.5% to 18.3%.
- What is the long-term trend for Arbutus Biopharma Corporation's earnings yield?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's earnings yield has grown at a -22.9% compound annual growth rate (CAGR), from -13.3% to -3.6%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.